The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Hydrolysis of the Anticancer Drug Cisplatin: Pitfalls in the Interpretation of Quantum Chemical Calculations
Abstract
All three hydrolysis reactions of the anticancer drug cisplatin, cis-[Pt(NH3)2Cl2], including the acidity constants (pKa) of the aqua complexes have been compared using a combined density functional theory (DFT) and continuum dielectric model (CDM) approach. The calculations predict very similar activation barriers (25-27 kcal/mol) and reaction free energies (0-2 kcal/mol) for each of the three hydrolysis reactions. The predicted relative free energies of both Pt(II) and Ru(II) anticancer complexes agree well with available experimental values. However, our calculated data strongly disagree with several recent computational studies that predicted the second and third hydrolysis to be thermodynamically highly unfavorable and thus would have ruled out the involvement of cis-[Pt(NH3)2(OH2)2](2+) and cis-[Pt(NH3)2(OH2)(OH)](+) in the mode of action of the drug. This controversy can be resolved by the fact that former computational predictions of activation and reaction free energies in solution were based on second-shell reactant adducts and product adducts, which are the correct endpoints of the intrinsic reaction coordinate in vacuo but artifacts in aqueous solution.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cellular processing of platinum anticancer drugs
Wang, D., & Lippard, S. J. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1691 · Cited by 3,801
Cited by
Cisplatin in cancer therapy: Molecular mechanisms of action
Dasari, S., & Bernard Tchounwou, P. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.07.025 · Cited by 5,537
Density functional theory for transition metals and transition metal chemistry
Cramer, C. J., & Truhlar, D. G. (2009) · Physical Chemistry Chemical Physics · doi:10.1039/b907148b · Cited by 1,648
Metadata
- Authors
- Lau, J. K.-C., & Deubel, D. V.
- Venue
- Journal of Chemical Theory and Computation
- Publisher
- American Chemical Society (ACS)
- Published
- 2005-12-13
- Volume
- 2
- Issue
- 1
- Pages
- 103-106
- ISSN
- 1549-9618 (ISSN-L)
- 1549-9626
- OpenAlex
- W1992379402
- Cited by
- 158
- References
- 1
- FWCI
- 3.25
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.